Trials / Unknown
UnknownNCT00261144
Collagenase in the Treatment of Cellulite
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Stony Brook University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.
Detailed description
This is an open label study of collagenase injection therapy for reduction and/or elimination of cellulite of the posterolateral thighs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Collagenase | One 0.58mg injection every two weeks for six weeks (total three 0.58mg injections) |
| BIOLOGICAL | Biological | Collagenase injection |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-02-01
- Completion
- 2014-03-01
- First posted
- 2005-12-02
- Last updated
- 2012-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00261144. Inclusion in this directory is not an endorsement.